Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Radiosurgery reirradiation for high-grade glioma recurrence: a retrospective analysis.
Pinzi V, Orsi C, Marchetti M, Milanesi IM, Bianchi LC, DiMeco F, Cuccarini V, Farinotti M, Ferroli P, Finocchiaro G, Franzini A, Fumagalli M, Silvani A, Fariselli L. Pinzi V, et al. Among authors: cuccarini v. Neurol Sci. 2015 Aug;36(8):1431-40. doi: 10.1007/s10072-015-2172-7. Epub 2015 Mar 25. Neurol Sci. 2015. PMID: 25805705 Free article.
FABP4 is a candidate marker of cerebellar liponeurocytomas.
Anghileri E, Eoli M, Paterra R, Ferroli P, Pollo B, Cuccarini V, Maderna E, Tringali G, Saini M, Salsano E, Finocchiaro G. Anghileri E, et al. Among authors: cuccarini v. J Neurooncol. 2012 Jul;108(3):513-9. doi: 10.1007/s11060-012-0853-0. Epub 2012 Apr 3. J Neurooncol. 2012. PMID: 22476608
CT and MRI of brain tumors.
Bruzzone MG, D'Incerti L, Farina LL, Cuccarini V, Finocchiaro G. Bruzzone MG, et al. Among authors: cuccarini v. Q J Nucl Med Mol Imaging. 2012 Apr;56(2):112-37. Q J Nucl Med Mol Imaging. 2012. PMID: 22617235 Review.
The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates.
Pellegatta S, Eoli M, Frigerio S, Antozzi C, Bruzzone MG, Cantini G, Nava S, Anghileri E, Cuppini L, Cuccarini V, Ciusani E, Dossena M, Pollo B, Mantegazza R, Parati EA, Finocchiaro G. Pellegatta S, et al. Among authors: cuccarini v. Oncoimmunology. 2013 Mar 1;2(3):e23401. doi: 10.4161/onci.23401. Oncoimmunology. 2013. PMID: 23802079 Free PMC article.
MRI in Glioma Immunotherapy: Evidence, Pitfalls, and Perspectives.
Aquino D, Gioppo A, Finocchiaro G, Bruzzone MG, Cuccarini V. Aquino D, et al. Among authors: cuccarini v. J Immunol Res. 2017;2017:5813951. doi: 10.1155/2017/5813951. Epub 2017 Apr 20. J Immunol Res. 2017. PMID: 28512646 Free PMC article. Review.
Survival gain in glioblastoma patients treated with dendritic cell immunotherapy is associated with increased NK but not CD8+ T cell activation in the presence of adjuvant temozolomide.
Pellegatta S, Eoli M, Cuccarini V, Anghileri E, Pollo B, Pessina S, Frigerio S, Servida M, Cuppini L, Antozzi C, Cuzzubbo S, Corbetta C, Paterra R, Acerbi F, Ferroli P, DiMeco F, Fariselli L, Parati EA, Bruzzone MG, Finocchiaro G. Pellegatta S, et al. Among authors: cuccarini v. Oncoimmunology. 2018 Jan 29;7(4):e1412901. doi: 10.1080/2162402X.2017.1412901. eCollection 2018. Oncoimmunology. 2018. PMID: 29632727 Free PMC article.
Stroke-like events after brain radiotherapy: a large series with long-term follow-up.
Di Stefano AL, Berzero G, Ducray F, Eoli M, Pichiecchio A, Farina LM, Cuccarini V, Brunelli MC, Diamanti L, Condette Auliac S, Salmaggi A, Silvani A, Giometto B, Pace A, Vidiri A, Bourdain F, Bastianello S, Ceroni M, Marchioni E. Di Stefano AL, et al. Among authors: cuccarini v. Eur J Neurol. 2019 Apr;26(4):639-650. doi: 10.1111/ene.13870. Epub 2019 Jan 10. Eur J Neurol. 2019. PMID: 30471162
40 results